| 000 | 01352 a2200361 4500 | ||
|---|---|---|---|
| 005 | 20250513212721.0 | ||
| 264 | 0 | _c20000627 | |
| 008 | 200006s 0 0 eng d | ||
| 022 | _a0344-5704 | ||
| 024 | 7 |
_a10.1007/s002800051026 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMcLaren, B R | |
| 245 | 0 | 0 |
_aNew chemotherapeutics in malignant mesothelioma: effects on cell growth and IL-6 production. _h[electronic resource] |
| 260 |
_bCancer chemotherapy and pharmacology _c2000 |
||
| 300 |
_a502-8 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAntimetabolites, Antineoplastic _xtherapeutic use |
| 650 | 0 | 4 |
_aAntineoplastic Agents, Phytogenic _xtherapeutic use |
| 650 | 0 | 4 |
_aCamptothecin _xanalogs & derivatives |
| 650 | 0 | 4 |
_aCell Division _xdrug effects |
| 650 | 0 | 4 | _aCell Line |
| 650 | 0 | 4 |
_aDeoxycytidine _xanalogs & derivatives |
| 650 | 0 | 4 | _aEnzyme-Linked Immunosorbent Assay |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInterleukin-6 _xbiosynthesis |
| 650 | 0 | 4 | _aIrinotecan |
| 650 | 0 | 4 |
_aMesothelioma _xdrug therapy |
| 650 | 0 | 4 | _aGemcitabine |
| 700 | 1 | _aRobinson, B W | |
| 700 | 1 | _aLake, R A | |
| 773 | 0 |
_tCancer chemotherapy and pharmacology _gvol. 45 _gno. 6 _gp. 502-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s002800051026 _zAvailable from publisher's website |
| 999 |
_c10805229 _d10805229 |
||